Bruce G. Allen Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$105K Buy
1,738
+253
+17% +$14.7K 0.07% 151
2025
Q4
$80.1K Sell
1,485
-1,408
-49% -$67.7K 0.05% 195
2025
Q3
$130K Sell
2,893
-279
-9% -$13K 0.09% 123
2025
Q2
$147K Sell
3,172
-261
-8% -$12.8K 0.11% 104
2025
Q1
$209K Sell
3,433
-105
-3% -$6.12K 0.17% 72
2024
Q4
$200K Buy
3,538
+133
+4% +$7.43K 0.16% 70
2024
Q3
$176K Buy
3,405
+614
+22% +$28.8K 0.14% 93
2024
Q2
$116K Sell
2,791
-694
-20% -$31.1K 0.1% 133
2024
Q1
$189K Buy
3,485
+732
+27% +$37.3K 0.16% 81
2023
Q4
$141K Buy
+2,753
New +$145K 0.13% 102

Other funds holding BMY

Bruce G. Allen Investments's BMY Position: Q1 2026 in Review

Bruce G. Allen Investments increased its Bristol-Myers Squibb (BMY) stake by 17% in Q1 2026, buying an estimated $14.7K and bringing the position to 1,738 shares worth $105K. The position accounts for 0.07% of the portfolio, ranked #151.

Bruce G. Allen Investments first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $209K in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Bruce G. Allen Investments held 1,738 shares of Bristol-Myers Squibb worth $105K as of Q1 2026.
  • Bruce G. Allen Investments bought 253 Bristol-Myers Squibb shares in Q1 2026, an estimated $14.7K.
  • Bristol-Myers Squibb made up 0.07% of Bruce G. Allen Investments's portfolio in Q1 2026, its #151 holding.
  • Bruce G. Allen Investments first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • Bruce G. Allen Investments's Bristol-Myers Squibb position peaked at $209K in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Bruce G. Allen Investments's 13F filing for Q1 2026, filed 8 May 2026.